Literature DB >> 20196659

Practices of participants in the college of american pathologists interlaboratory comparison program in cervicovaginal cytology, 2006.

Galen M Eversole1, Ann T Moriarty, Mary R Schwartz, Amy C Clayton, Rhona Souers, Lisa A Fatheree, Beth A Chmara, William D Tench, Michael R Henry, David C Wilbur.   

Abstract

CONTEXT: Liquid-based preparations (LBPs) and human papillomavirus testing have led to changes in cervical cytology practices. The College of American Pathologists attempts to track practice patterns using a supplemental questionnaire, which allows laboratories to report diagnostic practices.
OBJECTIVE: To analyze the 2006 reporting practices and to compare the results with the 2003 survey data.
DESIGN: Questionnaire was mailed to 1621 laboratories. Participants included laboratories enrolled in the 2006 College of American Pathologists Gynecologic Proficiency Testing Program or the educational Interlaboratory Comparison Program in Gynecologic Cytology.
RESULTS: Of the 679 responding laboratories (response rate, 42%), most (97.8%; n = 664) had implemented the Bethesda 2001 terminology. The median rate for all preparations with low-grade squamous intraepithelial lesions was 2.5% (2.9% for LBPs) compared with a 2003 median rate of 2.1%; the increase was confined to LBPs. Rates for high-grade squamous intraepithelial lesions (median, 0.5%) and atypical squamous cells have changed little. High-grade squamous intraepithelial lesions and unsatisfactory rates varied at statistically significant levels between types of LBPs. Most atypical squamous cell cases were subclassified as undetermined significance (median, 4.3%). The median ratio of atypical squamous cells to squamous intraepithelial lesions and carcinomas for all specimen types combined was 1.5, similar to the 2003 median ratio of 1.4. The median rates for findings of squamous cell abnormalities for 2006 were significantly higher for LBPs than for conventional smears.
CONCLUSIONS: Most responding laboratories have implemented the Bethesda 2001 terminology. There is an increase in LBP low-grade squamous intraepithelial lesion rates when compared with 2003 data. Liquid-based preparations have higher median squamous intraepithelial lesion and atypical squamous cell rates.

Entities:  

Mesh:

Year:  2010        PMID: 20196659     DOI: 10.5858/134.3.331

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  16 in total

1.  Progression or Regression? - Strengths and Weaknesses of the New Munich Nomenclature III for Cervix Cytology.

Authors:  Z Hilal; C Tempfer; S Schiermeier; J Reinecke; C Ruppenkamp; Z Hilal
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-10       Impact factor: 2.915

2.  Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years.

Authors:  Xian Wen Jin; Laura Lipold; Julie Foucher; Andrea Sikon; Jennifer Brainard; Jerome Belinson; Sarah Schramm; Kelly Nottingham; Bo Hu; Michael B Rothberg
Journal:  J Gen Intern Med       Date:  2016-07-14       Impact factor: 5.128

3.  The impact of liquid-based cytology in decreasing the incidence of cervical cancer.

Authors:  Randall K Gibb; Mark G Martens
Journal:  Rev Obstet Gynecol       Date:  2011

4.  Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.

Authors:  Yu-Jin Koo; Ho-Suap Hahn; In-Ho Lee; Kyung-Taek Lim; Ki-Heon Lee; Hye-Sun Kim; Tae-Jin Kim; Yi-Kyeong Chun; Hy-Sook Kim; Sung-Ran Hong
Journal:  Virchows Arch       Date:  2013-10-01       Impact factor: 4.064

5.  Digital imaging in cytopathology.

Authors:  Walid E Khalbuss; Liron Pantanowitz; Anil V Parwani
Journal:  Patholog Res Int       Date:  2011-07-19

6.  Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females.

Authors:  Diane M Harper; Stephen L Vierthaler
Journal:  ISRN Obstet Gynecol       Date:  2011-11-02

Review 7.  Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?

Authors:  R Marshall Austin; Chengquan Zhao
Journal:  Cytojournal       Date:  2014-05-22       Impact factor: 2.091

8.  3q26 amplification is an effective negative triage test for LSIL: a historical prospective study.

Authors:  Erica R Heitmann; Kamani M Lankachandra; Jeff Wall; George D Harris; Hollie J McKinney; G Reza Jalali; Yogita Verma; Eric Kershnar; Michael W Kilpatrick; Petros Tsipouras; Diane M Harper
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

9.  Historical Analysis of the Brazilian Cervical Cancer Screening Program from 2006 to 2013: A Time for Reflection.

Authors:  Ricardo Filipe Alves Costa; Adhemar Longatto-Filho; Céline Pinheiro; Luiz Carlos Zeferino; José Humberto Fregnani
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

10.  Patterns of cervical cytological abnormalities according to the Human Development Index in the northeast region of Brazil.

Authors:  José De Ribamar Pinho-França; Maria Bethânia Da Costa Chein; Luiz Claudio Santos Thuler
Journal:  BMC Womens Health       Date:  2016-08-12       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.